QURE
Companies
NASDAQ
Uniqure N.V.
Health Care
$14.31
-$3.35 (-18.97%)
Price Chart
Overview
About QURE
uniqure is delivering on the promise of gene therapy - single treatments with potentially curative results. we are leveraging our modular and validated technology platform to rapidly advance a pipeline of proprietary and partnered gene therapies to treat patients with severe genetic diseases.
Market Cap
$258.8M
Volume
31.8M
Avg. Volume
32.3M
P/E Ratio
-5.0032682
Dividend Yield
0.00%
Employees
534.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.02
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, QURE shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$258.8M
Volume31.8M
P/E Ratio-5.00
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 9, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025